XTalks

APRIL 22, 2025

The postpandemic era has accelerated demand across healthcare and life sciences, rewarding companies that address emerging patient and provider needs. In 2024, Canadian health spending climbed 5.7% to approximately $268billion, driven by aging demographics and new provider agreements. Across the US, healthcare is poised to deliver 45% of all job gains through2032, reflecting sustained sector momentum.

Life Science 59

Life Science Pharmacy Sales Nurses 59

Rethinking Clinical Trials

APRIL 22, 2025

Even in minimal-risk studies that do not use the standard consent process, there may be value in informing participants about the research. Such notifications should be considered the default for clinical trials conducted under a waiver of informed consent, argue the authors of a new report from the NIH Pragmatic Trials Collaboratory. The open-access article was published online ahead of print this week in Learning Health Systems.

Research 147

Research Clinical Trials Clinical Trials Trials 147

Bio Pharma Dive

APRIL 21, 2025

A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug Wegovy two years after reporting initial Phase 3 results.

FDA Approval 351

FDA Approval Regulation Drugs 351

ACRP blog

APRIL 25, 2025

At the latest meeting of the Association of Clinical Research Professionals (ACRP)-led Partners Advancing the Clinical Research Workforce (PACRW) consortium, the focus for these extraordinary times in human subjects research was on what levers need to be pulled by the consortiums members to bend the curve toward a better future for stakeholders in what is often an under-recognized and under-resourced segment of the larger healthcare workforce.

Clinical Research 99

Clinical Research Research Clinical Trials Clinical Trials 99

Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group

Let’s face it—most ethics and compliance trainings aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, relevant, and maybe even enjoyable! Join expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training programs. You’ll discover creative strategies to turn traditionally dry topics into meaningful learning experiences that resonate and drive real change.

Compliance

Pharmaceutical Technology

APRIL 23, 2025

The agreement gives Boehringer access to Tessellates novel approach targeting ALT-dependent tumours.

243

243

XTalks

APRIL 25, 2025

This week, LEO Pharma announced the publication of pivotal Phase III clinical trial results in The Lancet for its topical delgocitinib cream to treat severe chronic hand eczema (CHE). Results from the trial showed delgocitinib to have superior efficacy and safety over oral alitretinoin, the current standard of care for CHE. The DELTA FORCE trial is the first head-to-head Phase III study comparing a topical treatment with a systemic therapy for CHE.

Trials 66

Trials Dermatology Clinical Trials Clinical Trials 66

FDA Law Blog

APRIL 21, 2025

By John W.M. Claud & Michelle L. Butler Recent reductions in force (RIFs) and leadership changes at FDA are already affecting key agency functionsand as the administration plans a broader reorganization, the impact will likely grow. One area drawing increasing attention is how these changes will affect the drug development and review process. As reported by the Wall Street Journal last week , reviews of both innovative and follow-on drugs have been caught in a traffic jam, largely due to a

Drugs 64

Drugs Scientist Development Research 64

Pharmaceutical Technology

APRIL 23, 2025

The lawsuit filings are the latest turn in a long-running legal saga between GLP-1RAs makers and compounders.

Marketing 240

Marketing 240

Pharma Times

APRIL 22, 2025

The SHIELD-Utah study compared Novavaxs vaccine to Pfizer/BioNTech mRNA 2024 to 2025 vaccine

Vaccination 139

Vaccination Vaccine 139

Bio Pharma Dive

APRIL 22, 2025

The big pharma joined several of its peers in committing to invest billions of dollars in new and expanded manufacturing facilities in the U.S.

Production 258

Production Manufacturing Drugs 258

Advertisement

Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness

Trials

ACRP blog

APRIL 22, 2025

This is a sponsored message. Helen Keller once wrote: True happiness is not attained through self-gratification, but through fidelity to a worthy purpose. Nothing could be truer for the millions of clinical research professionals steadfastly committed to helping advance treatments that transform lives. These everyday unsung heroes occupy every corner of our industry from small clinician-run sites to large academic medical centers; from global pharmaceutical companies to nimble biotech startups

Research 59

Research Clinical Research Clinical Trials Clinical Trials 59

Pharmaceutical Technology

APRIL 22, 2025

Roche is set to invest $50bn in pharmaceuticals and diagnostics in the US over the coming five years to bolster its presence in the country.

239

239

XTalks

APRIL 22, 2025

As the prevalence of metabolic diseases such as diabetes, obesity and prediabetes continues to rise globally, there is an urgent need for innovative therapies that move beyond traditional hormone replacement strategies. Steffen-Sebastian Bolz, MD, PhD Executive Board Member, Chief Scientific Officer Aphaia Pharma Aphaia Pharma is redefining the landscape of metabolic disorder treatment by leveraging the bodys inherent biological processes.

Hormones 52

Hormones Clinical Research Clinical Trials Clinical Trials 52

Bio Pharma Dive

APRIL 24, 2025

The drugmaker absorbed additional tariff-related costs in the first quarter, but has taken steps to lower the financial impact it’ll have for the rest of the year and beyond.

252

252

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Drug Patent Watch

APRIL 22, 2025

"The Russian Pharmaceutical Industry: A Strategic Evolution Unfolding As the global pharmaceutical landscape continues to shift, one country is making a bold move: Russia. With a growing focus on domestic production and technological innovation, the Russian pharmaceutical industry is poised for significant growth. In this in-depth report, we dive into the key players, strategic evolution, and technological advancements driving the industry forward.

Manufacturing 55

Manufacturing Production Marketing 55

Pharmaceutical Technology

APRIL 24, 2025

Biogen Netherlands has received marketing authorisation from the UK MHRA for its Skyclarys to treat Friedreich's ataxia.

Marketing 233

Marketing 233

XTalks

APRIL 22, 2025

As consumer interest in protein-enriched foods continues to grow, food manufacturers are increasingly seeking high-quality, functional ingredients that enhance both nutrition and sensory appeal. Plant-based proteins are interesting as versatile solutions for a wide range of food applications. The use of faba bean is gaining traction in a wide range of savoury applications.

Protein 52

Protein Manufacturing Production Marketing 52

Bio Pharma Dive

APRIL 24, 2025

The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene beforehand with a targeted medication.

188

188

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Drug Patent Watch

APRIL 22, 2025

"Game Changer Alert: Are You Leaving Millions on the Table? As a pharmaceutical executive, you know the importance of staying ahead of the competition. But are you overlooking a crucial aspect of your generic launch strategy? I recently came across a fascinating article from @DrugPatentWatch that highlights the untapped potential of integrating clinical trials and the 505(b)(2) pathway into your pharmaceutical portfolio management.

Clinical Trials 53

Clinical Trials Clinical Trials Trials Marketing 53

Pharmaceutical Technology

APRIL 25, 2025

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final resolution.

Drugs 189

Drugs 189

Medical Xpress

APRIL 20, 2025

When humans are trying to grasp a complicated concept or solve a problem, they might suddenly feel like they have gained a deeper understanding or think of something they had not thought of before. This type of 'aha' moments, broadly referred to as 'insight', can play a key role in their ultimate ability to acquire new valuable knowledge or solve the problem at hand.

117

117

Bio Pharma Dive

APRIL 25, 2025

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid to focus resources on a pair of cancer cell therapies.

187

187

Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk

In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?

Compliance

Drug Discovery World podcast

APRIL 22, 2025

The latest episode of the DDW Highlightspodcast is now available to listen to below. DDWs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In a week of financial uncertainty for the industry, our round-up focuses on the power of partnership to accelerate drug discovery, from the prevention of respiratory infections, to mapping gene activity in inflammatory bowel disease.

Gene 52

Gene Drugs 52

Pharmaceutical Technology

APRIL 21, 2025

The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for Huntington's disease.

Drugs 179

Drugs 179

Medical Xpress

APRIL 19, 2025

Tel Aviv University-led research has found that infants prescribed acid-suppressive medications during their first six months of life had an increased risk of developing celiac disease autoimmunity under certain study conditions.

Development 115

Development Research 115

Bio Pharma Dive

APRIL 22, 2025

Henry Gosebruch is now chief executive of the spinout, which has roughly $2.5 billion and plans to use dealmaking to build a research pipeline targeting cancer, viruses and the immune system.

Research 179

Research 179

Advertisement

Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.

Life Science

pharmaphorum

APRIL 22, 2025

Roche will spend $50bn on manufacturing and R&D facilities in the US, with a pledge to export more medicines from the US than it imports

Manufacturing 110

Manufacturing Medicine 110

Pharmaceutical Technology

APRIL 23, 2025

ConcertAI has announced an agreement with Bayer that allows the latter to utilise its Translational360 and AI SaaS solutions.

147

147

Medical Xpress

APRIL 19, 2025

When you see a bag of carrots at the grocery store, does your mind go to potatoes and parsnips or buffalo wings and celery?

114

114

Bio Pharma Dive

APRIL 25, 2025

The company is looking to the highly anticipated launch of a closely watched HIV medicine to offset weakening demand for Trodelvy and its cancer cell therapies.

Sales 170

Sales Medicine Drugs 170

Advertisement

Clinical Supply